DPP-4 inhibitor-related pemphigoid

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 1997卷 / 1期
关键词：
D O I：
10.1007/s40278-024-53684-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [21] A Scalable Synthesis of an Azabicyclooctanyl Derivative, a Novel DPP-4 Inhibitor
    Fei, Zhongbo
    Wu, Quanbing
    Zhang, Fei
    Cao, Yudong
    Liu, Chuanqin
    Shieh, Wen-Chung
    Xue, Song
    McKenna, Joe
    Prasad, Kapa
    Prashad, Mahavir
    Baeschlin, Daniel
    Namoto, Kenji
    JOURNAL OF ORGANIC CHEMISTRY, 2008, 73 (22): : 9016 - 9021
  • [22] DPP-4 INHIBITOR THERAPY IN PATIENTS AFTER PANCREATIC TRANSPLANT
    Ergin, Ahmet B.
    Poggio, Emilio
    Krishnamurthi, Venkatesh
    Jaber, Tania
    Hatipoglu, Betul A.
    ENDOCRINE PRACTICE, 2015, 21 (06) : 567 - 573
  • [23] Onglyza®, new inhibitor of DPP-4, now available and repaid
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (09): : 309 - 309
  • [24] Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
    Kishimoto, Miyako
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 187 - 195
  • [25] DPP-4 inhibitors
    Ahren, Bo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) : 517 - 533
  • [26] DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis
    Padron, Simonette
    Rogers, Everett
    Beckler, Michelle Demory
    Kesselman, Marc
    BMJ CASE REPORTS, 2019, 12 (08)
  • [27] The safety of DPP-4 inhibitor and SGLT2 inhibitor combination therapies
    Molina-Vega, Maria
    Munoz-Garach, Araceli
    Fernandez-Garcia, Jose C.
    Tinahones, Francisco J.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (08) : 815 - 824
  • [28] Bullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?
    Aikaterini Patsatsi
    Aikaterini Kyriakou
    Parthena Meltzanidou
    Anastasia Trigoni
    Foteini Lamprou
    Miltiadis Kokolios
    Anastasia Giannakou
    European Journal of Dermatology, 2018, 28 : 711 - 713
  • [29] Bullous pemphigoid in patients with DPP-4 inhibitors at the onset of disease: does this differ from common bullous pemphigoid?
    Patsatsi, Aikaterini
    Kyriakou, Aikaterini
    Meltzanidou, Parthena
    Trigoni, Anastasia
    Lamprou, Foteini
    Kokolios, Miltiadis
    Giannakou, Anastasia
    EUROPEAN JOURNAL OF DERMATOLOGY, 2018, 28 (05) : 711 - 713
  • [30] Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid
    Chijiwa, Chika
    Takeoka, Shintaro
    Kamata, Masahiro
    Tateishi, Mihoko
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Watanabe, Shinichi
    Tada, Yayoi
    JOURNAL OF DERMATOLOGY, 2018, 45 (05): : 596 - 599
12345